ATYR Price / Book | aTYR PHARMA INC

aTYR PHARMA INC Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

aTYR PHARMA INC price/book ratio for the quarter ending 2026-06-30 was 1.23, a 80.47% decline year-over-year.
aTYR PHARMA INC price/book ratio for the quarter ending 2026-03-31 was 1.31, a 63.32% decline year-over-year.
aTYR PHARMA INC price/book ratio for the quarter ending 2025-12-31 was 1.13, a 74.02% decline year-over-year.
aTYR PHARMA INC price/book ratio for the quarter ending 2025-09-30 was 0.88, a 56.87% decline year-over-year.
aTYR PHARMA INC price/book ratio for fiscal 2026 was 1.23.
aTYR PHARMA INC price/book ratio for fiscal 2025 was 1.13, a 74.02% decline from fiscal 2024.
aTYR PHARMA INC price/book ratio for fiscal 2024 was 4.34, a 341.42% increase from fiscal 2023.
aTYR PHARMA INC price/book ratio for fiscal 2023 was 0.98, a 8.88% increase from fiscal 2022.

Available history: 2015-06-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.23	$59.81M	$48.79M
2026-03-31	1.31	$76.11M	$57.93M
2025-12-31	1.13	$76.18M	$67.48M
2025-09-30	0.88	$70.68M	$80.24M
2025-06-30	6.28	$469.93M	$74.85M
2025-03-31	3.58	$268.79M	$75.05M
2024-12-31	4.34	$304.22M	$70.02M
2024-09-30	2.04	$133.43M	$65.33M
2024-06-30	1.45	$118.24M	$81.61M
2024-03-31	1.58	$133.29M	$84.47M
2023-12-31	0.98	$89.23M	$90.66M
2023-09-30	0.94	$92.52M	$98.39M
2023-06-30	1.16	$123.22M	$106.24M
2023-03-31	1.02	$112.01M	$109.88M
2022-12-31	0.9	$64.6M	$71.46M
2022-09-30	1.13	$87.03M	$77.18M
2022-06-30	0.92	$79.6M	$86.64M
2022-03-31	1.52	$150.1M	$98.55M
2021-12-31	1.9	$207.61M	$109.3M
2021-09-30	2.15	$252.34M	$117.61M
2021-06-30	1.94	$79.58M	$40.98M
2021-03-31	1.43	$71.25M	$49.7M
2020-12-31	1.35	$42.75M	$31.65M
2020-09-30	1	$32.27M	$32.16M
2020-06-30	1.15	$41.66M	$36.1M
2020-03-31	0.62	$26.19M	$42.13M
2019-12-31	0.77	$16.23M	$21.19M
2019-09-30	0.51	$13.62M	$26.74M
2019-06-30	0.6	$18.09M	$30.23M
2019-03-31	9.08	$267.71M	$29.49M
2018-12-31	0.45	$15.18M	$33.65M
2018-09-30	8.72	$339.93M	$38.99M
2018-06-30	8.38	$380.38M	$45.38M
2018-03-31	24.85	$1.35B	$54.5M
2017-12-31	22.72	$1.46B	$64.25M
2017-09-30	29.06	$2.1B	$72.29M
2017-06-30	28.34	$1.13B	$40.03M
2017-03-31	22.98	$1.17B	$50.71M
2016-12-31	11.38	$714.72M	$62.8M
2016-09-30	14.27	$1.06B	$73.99M
2016-06-30	10.66	$923.09M	$86.57M
2016-03-31	13	$1.31B	$100.43M
2015-12-31	28.31	$3.26B	$115.05M
2015-09-30	26.29	$3.4B	$129.16M
2015-06-30	43.99	$6.13B	$139.34M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.23	$59.81M	$48.79M
2025-12-31	1.13	$76.18M	$67.48M
2024-12-31	4.34	$304.22M	$70.02M
2023-12-31	0.98	$89.23M	$90.66M
2022-12-31	0.9	$64.6M	$71.46M
2021-12-31	1.9	$207.61M	$109.3M
2020-12-31	1.35	$42.75M	$31.65M
2019-12-31	0.77	$16.23M	$21.19M
2018-12-31	0.45	$15.18M	$33.65M
2017-12-31	22.72	$1.46B	$64.25M
2016-12-31	11.38	$714.72M	$62.8M
2015-12-31	28.31	$3.26B	$115.05M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Quince Therapeutics, Inc. (QNCX)	United States	$0.031B
CEL SCI CORP (CVM)	United States	$0.030B	-0.81
Scilex Holding Co (SCLX)	United States	$0.042B	-0.14
Metagenomi Therapeutics, Inc. (MGX)	United States	$0.044B	-0.48
Estrella Immunopharma, Inc. (ESLA)	United States	$0.020B
LeonaBio, Inc. (LONA)	United States	$0.047B	-0.61
Jasper Therapeutics, Inc. (JSPR)	United States	$0.020B	-0.37
Instil Bio, Inc. (TIL)	United States	$0.048B	-1.73
Tevogen Inc. (TVGN)	United States	$0.049B
BioCardia, Inc. (BCDA)	United States	$0.016B